Safety of hepatitis C virus (HCV)-treated donors for kidney transplantation excluding occult HCV infection through kidney biopsies
Transpl Int
.
2018 Aug;31(8):938-939.
doi: 10.1111/tri.13270.
Epub 2018 May 11.
Authors
Rosana Gelpi
1
2
,
Camino Rodríguez-Villar
2
,
David Paredes
2
,
Rebeca Roque
2
,
Angel Ruiz
2
,
Ramon Adalia
2
,
Erika de Sousa
1
,
Ignacio Revuelta
1
,
Manuel Sole
3
,
Miguel Martinez
4
,
Mireia Navarro
4
,
Sabela Lens
5
,
Federico Oppenheimer
1
,
Fritz Diekmann
1
Affiliations
1
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.
2
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.
3
Pathology Department, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.
4
Department of Clinical Microbiology, Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain.
5
Liver Unit, IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain.
PMID:
29687492
DOI:
10.1111/tri.13270
No abstract available
Publication types
Letter
MeSH terms
Antiviral Agents / therapeutic use*
Hepatitis C / drug therapy*
Humans
Kidney / virology*
Kidney Transplantation*
Tissue Donors*
Substances
Antiviral Agents